Post-earnings recap
Reported
Tue, May 7, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio Rad Laboratories reported lower-than-expected earnings per share, which led to a significant drop in the stock price by 6.62%. The lack of revenue details and guidance may raise concerns among investors about the company's future performance. Management's cautious tone suggests they are aware of the challenges ahead and are focusing on internal efficiencies.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.68 | N/A | -35.55% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed concerns about current market conditions. They are prioritizing internal improvements to navigate the challenges.
Management acknowledged the challenges faced in the quarter.
They emphasized a focus on cost control and operational efficiency.